Ganoderic acid AM1CAS# 149507-55-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 149507-55-1 | SDF | Download SDF |
PubChem ID | 10346401 | Appearance | Powder |
Formula | C30H42O7 | M.Wt | 514.66 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (6R)-6-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid | ||
SMILES | CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C | ||
Standard InChIKey | RDMQPKIDHAFXKA-AQJFDGEUSA-N | ||
Standard InChI | InChI=1S/C30H42O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18,21-22,34H,8-14H2,1-7H3,(H,36,37)/t15-,16?,18-,21?,22+,28+,29-,30+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Ganoderic acid AM1 treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.8+/-0.7 microM. |
Ganoderic acid AM1 Dilution Calculator
Ganoderic acid AM1 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.943 mL | 9.7152 mL | 19.4303 mL | 38.8606 mL | 48.5758 mL |
5 mM | 0.3886 mL | 1.943 mL | 3.8861 mL | 7.7721 mL | 9.7152 mL |
10 mM | 0.1943 mL | 0.9715 mL | 1.943 mL | 3.8861 mL | 4.8576 mL |
50 mM | 0.0389 mL | 0.1943 mL | 0.3886 mL | 0.7772 mL | 0.9715 mL |
100 mM | 0.0194 mL | 0.0972 mL | 0.1943 mL | 0.3886 mL | 0.4858 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hypocrellin C
Catalog No.:BCN3398
CAS No.:149457-83-0
- Traxillaside
Catalog No.:BCN6917
CAS No.:149415-62-3
- Poncirin
Catalog No.:BCN2590
CAS No.:14941-08-3
- NE 100 hydrochloride
Catalog No.:BCC7573
CAS No.:149409-57-4
- Cidofovir dihydrate
Catalog No.:BCC4247
CAS No.:149394-66-1
- UNC2881
Catalog No.:BCC5362
CAS No.:1493764-08-1
- 1,2,3,4,6-O-Pentagalloylglucose
Catalog No.:BCN2338
CAS No.:14937-32-7
- UNC2250
Catalog No.:BCC4876
CAS No.:1493694-70-4
- AACOCF3
Catalog No.:BCC7075
CAS No.:149301-79-1
- Cytochalasin B
Catalog No.:BCN7084
CAS No.:14930-96-2
- pp60 c-src (521-533) (phosphorylated)
Catalog No.:BCC5851
CAS No.:149299-77-4
- 1-Dehydroxy-23-deoxojessic acid
Catalog No.:BCN1663
CAS No.:149252-87-9
- Marmin
Catalog No.:BCN1665
CAS No.:14957-38-1
- Stachybotramide
Catalog No.:BCN6969
CAS No.:149598-71-0
- Impentamine dihydrobromide
Catalog No.:BCC7197
CAS No.:149629-70-9
- MOG (35-55)
Catalog No.:BCC3670
CAS No.:149635-73-4
- Vorinostat (SAHA, MK0683)
Catalog No.:BCC2145
CAS No.:149647-78-9
- Nafadotride
Catalog No.:BCC7025
CAS No.:149649-22-9
- Chrysosplenol D
Catalog No.:BCN1666
CAS No.:14965-20-9
- Isogambogic acid
Catalog No.:BCN3078
CAS No.:149655-52-7
- Isomorellinol
Catalog No.:BCN3075
CAS No.:149655-53-8
- Pefloxacin Mesylate Dihydrate
Catalog No.:BCC5089
CAS No.:149676-40-4
- Stachybotrolide
Catalog No.:BCN6968
CAS No.:149691-31-6
- AHU-377(Sacubitril)
Catalog No.:BCC4088
CAS No.:149709-62-6
Triterpenoids of Ganoderma theaecolum and their hepatoprotective activities.[Pubmed:25111010]
Fitoterapia. 2014 Oct;98:254-9.
Five new lanostane triterpenoids, ganoderic acid XL1 (1), ganoderic acid XL2 (2), 20-hydroxy-Ganoderic acid AM1 (3), ganoderenic acid AM1 (4) and ganoderesin C (5), together with five known triterpenoids (6-10) were isolated from the fruiting bodies of Ganoderma theaecolum. Chemical structures were elucidated on the basis of spectroscopic evidence, including 1D, 2D NMR, mass spectrometric data and circular dichroism spectra. Compounds 1, 4, 5, 8, 9 and 10 (10 muM) exhibited hepatoprotective activities against DL-galactosamine-induced cell damage in HL-7702 cells.
Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells.[Pubmed:20092987]
Phytomedicine. 2010 Jul;17(8-9):606-13.
To elucidate the cytotoxicity mechanism of Ganoderma triterpenes, a chemoproteomic study using five purified ganoderic acids, ganoderic acid F (GAF), ganoderic acid K (GAK), ganoderic B (GAB), ganoderic acid D (GAD) and Ganoderic acid AM1 (GAAM1) was conducted. GAF, GAK, GAB, GAD and GAAM1 treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.5+/-0.6 microM, 15.1+/-0.5 microM, 20.3+/-0.4 microM, 17.3+/-0.3 microM, 19.8+/-0.7 microM, respectively. The protein expression profiles of HeLa cells treated with each ganoderic acid at dose of 15 microM for 48 h were checked using two-dimensional electrophoresis (2-DE). The possible target-related proteins of ganoderic acids, i.e. proteins with same change tendency in all five ganoderic acids-treated groups compared with control, were identified using MALDI-TOF MS/MS. Twelve proteins including human interleukin-17E, eukaryotic translation initiation factor 5A (eIF5A), peroxiredoxin 2, ubiquilin 2, Cu/Zn-superoxide dismutase, 14-3-3 beta/alpha, TPM4-ALK fusion oncoprotein type 2, PP2A subunit A PR65-alpha isoform, nucleobindin-1, heterogeneous nuclear ribonucleoprotein K, reticulocalbin 1 and chain A of DJ-1 protein were identified. Ganoderic acids might exert their cytotoxicity by altering proteins involved in cell proliferation and/or cell death, carcinogenosis, oxidative stress, calcium signaling and ER stress.